Lenalidomide Impurity 1 with CAS No: 2197414-57-4 is an impurity standard of Lenalidomide.
Lenalidomide is a pharmaceutical agent with diverse applications, prominently utilized in the treatment of multiple myeloma, myelodysplastic syndromes, and certain types of lymphomas. It belongs to the class of immunomodulatory drugs and exerts its therapeutic effects through various mechanisms. Lenalidomide has immunomodulatory, anti-angiogenic, and direct antitumor properties. It enhances the immune systems response against cancer cells, inhibits the growth of new blood vessels that support tumor growth, and induces apoptosis in certain cancer cells. Additionally, lenalidomide has shown efficacy in treating anemia associated with myelodysplastic syndromes.
Buy high quality Lenalidomide Impurity 1 from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Lenalidomide Impurity 1

Lenalidomide Impurity 1

Lenalidomide Impurity 1
Zoom Image
CAT. No. CP-L27002
CAS. No. 2197414-57-4
Mol. F. C13H15N3O4
Mol. Wt. 277.28
Stock Status In Stock
Sample PDF VIEW COA Sample PDF VIEW MSDS
  • Category: Impurity Standards
  • Synonyms: NA
  • Chemical Name: 5-Amino-4-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoic acid

Lenalidomide Impurity 1 is an essential reference standard used in the pharmaceutical industry for research and development (R&D). It plays a key role in quality control, stability testing, and ensuring regulatory compliance in Lenalidomide-based drug formulations. This impurity is critical for the development of analytical methods, toxicological studies, and the calibration of laboratory instruments to ensure accurate and reliable results.

Note: This product is strictly intended for research and development purposes and is not suitable for animal or human use.

Request for Quotation : Lenalidomide Impurity 1

Please enter pack size
Please enter quantity
Please enter phone number
Enter 10 digit contact number
Enter only number
Please enter your full name
Please enter only alphabets
Please enter company name
Please enter your valid email
Please enter your valid email id
Please select country
Please select state
Please select city

Please select captcha
Please wait...